BACKGROUND:Fatigue is a common and debilitating feature of multiple sclerosis (MS) that remains without reliably effective treatment. Transcranial direct current stimulation (tDCS) is a promising option for fatigue reduction. We developed a telerehabilitation protocol that delivers tDCS to participants at home using specially designed equipment and real-time supervision (remotely supervised transcranial direct current stimulation (RS-tDCS)). OBJECTIVE: To evaluate whether tDCS can reduce fatigue in individuals with MS. METHODS: Dorsolateral prefrontal cortex left anodal tDCS was administered using a RS-tDCS protocol, paired with 20 minutes of cognitive training. Here, two studies are considered. Study 1 delivered 10 open-label tDCS treatments (1.5 mA; n = 15) compared to a cognitive training only condition ( n = 20). Study 2 was a randomized trial of active (2.0 mA, n = 15) or sham ( n = 12) delivered for 20 sessions. Fatigue was assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS)-Fatigue Short Form. RESULTS AND CONCLUSION: In Study 1, there was modest fatigue reduction in the active group (-2.5 ± 7.4 vs -0.2 ± 5.3, p = 0.30, Cohen's d = -0.35). However, in Study 2 there was statistically significant reduction for the active group (-5.6 ± 8.9 vs 0.9 ± 1.9, p = 0.02, Cohen's d = -0.71). tDCS is a potential treatment for MS-related fatigue.
RCT Entities:
BACKGROUND:Fatigue is a common and debilitating feature of multiple sclerosis (MS) that remains without reliably effective treatment. Transcranial direct current stimulation (tDCS) is a promising option for fatigue reduction. We developed a telerehabilitation protocol that delivers tDCS to participants at home using specially designed equipment and real-time supervision (remotely supervised transcranial direct current stimulation (RS-tDCS)). OBJECTIVE: To evaluate whether tDCS can reduce fatigue in individuals with MS. METHODS: Dorsolateral prefrontal cortex left anodal tDCS was administered using a RS-tDCS protocol, paired with 20 minutes of cognitive training. Here, two studies are considered. Study 1 delivered 10 open-label tDCS treatments (1.5 mA; n = 15) compared to a cognitive training only condition ( n = 20). Study 2 was a randomized trial of active (2.0 mA, n = 15) or sham ( n = 12) delivered for 20 sessions. Fatigue was assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS)-Fatigue Short Form. RESULTS AND CONCLUSION: In Study 1, there was modest fatigue reduction in the active group (-2.5 ± 7.4 vs -0.2 ± 5.3, p = 0.30, Cohen's d = -0.35). However, in Study 2 there was statistically significant reduction for the active group (-5.6 ± 8.9 vs 0.9 ± 1.9, p = 0.02, Cohen's d = -0.71). tDCS is a potential treatment for MS-related fatigue.
Entities:
Keywords:
Fatigue; multiple sclerosis; tDCS; tES; telerehabilitation; transcranial direct current stimulation
Authors: Pedro Shiozawa; Felipe Fregni; Isabela M Benseñor; Paulo A Lotufo; Marcelo T Berlim; Jeff Z Daskalakis; Quirino Cordeiro; André R Brunoni Journal: Int J Neuropsychopharmacol Date: 2014-04-08 Impact factor: 5.176
Authors: F Fregni; M A Nitsche; C K Loo; A R Brunoni; P Marangolo; J Leite; S Carvalho; N Bolognini; W Caumo; N J Paik; M Simis; K Ueda; H Ekhitari; P Luu; D M Tucker; W J Tyler; J Brunelin; A Datta; C H Juan; G Venkatasubramanian; P S Boggio; M Bikson Journal: Clin Res Regul Aff Date: 2015-03-01
Authors: Catarina Saiote; Thomas Goldschmidt; Charles Timäus; Martijn D Steenwijk; Alexander Opitz; Andrea Antal; Walter Paulus; Michael A Nitsche Journal: Restor Neurol Neurosci Date: 2014 Impact factor: 2.406
Authors: Sandra Carvalho; Jorge Leite; Camila B Pinto; Leslie R Morse; Ross Zafonte; Felipe Fregni Journal: J Spinal Cord Med Date: 2018-03-28 Impact factor: 1.985
Authors: Sarvenaz Rahimibarghani; Mohaddeseh Azadvari; Seyede Zahra Emami-Razavi; Mohammad Hossein Harirchian; Shahram Rahimi-Dehgolan; Hamid R Fateh Journal: Int J MS Care Date: 2022-06-22
Authors: Tracy D Vannorsdall; Ermiece Straub; Christina Saba; Mallory Blackwood; Jingyi Zhang; Keren Stearns; Karen Lisa Smith Journal: Support Care Cancer Date: 2020-10-21 Impact factor: 3.603
Authors: Marom Bikson; Colleen A Hanlon; Adam J Woods; Bernadette T Gillick; Leigh Charvet; Claus Lamm; Graziella Madeo; Adrienn Holczer; Jorge Almeida; Andrea Antal; Mohammad Reza Ay; Chris Baeken; Daniel M Blumberger; Salvatore Campanella; Joan A Camprodon; Lasse Christiansen; Colleen Loo; Jennifer T Crinion; Paul Fitzgerald; Luigi Gallimberti; Peyman Ghobadi-Azbari; Iman Ghodratitoostani; Roland H Grabner; Gesa Hartwigsen; Akimasa Hirata; Adam Kirton; Helena Knotkova; Evgeny Krupitsky; Paola Marangolo; Ester M Nakamura-Palacios; Weronika Potok; Samir K Praharaj; Christian C Ruff; Gottfried Schlaug; Hartwig R Siebner; Charlotte J Stagg; Axel Thielscher; Nicole Wenderoth; Ti-Fei Yuan; Xiaochu Zhang; Hamed Ekhtiari Journal: Brain Stimul Date: 2020-05-12 Impact factor: 8.955